Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity. Kousin-Ezewu O, Azzopardi L, Parker RA, Tuohy O, Compston A, Coles A, Jones J Neurology. 2014 May 16. PMID: 24838790. Abstract CommentRecommendBookmarkWatch